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Transcription of the Xist gene triggers X chromosome inactivation in cis and is therefore silenced on the X
chromosome that remains active. DNA methylation contributes to this silencing, but the mechanism is
unknown. As methylated DNA binding proteins (MBPs) are potential mediators of gene silencing by DNA
methylation, we asked whether MBP-deficient cell lines could maintain Xist repression. The absence of Mbd2
caused significant low-level reactivation of Xist, but silencing was restored by exogenous Mbd2. In contrast,
deficiencies of Mbd1, MeCP2, and Kaiso had no detectable effect, indicating that MBPs are not functionally
redundant at this locus. Xist repression in Mbd2-null cells was hypersensitive to the histone deacetylase
inhibitor trichostatin A and to depletion of the DNA methyltransferase Dnmt1. These synergies implicate
Mbd2 as a mediator of the DNA methylation signal at this locus. The presence of redundant mechanisms to
enforce repression at Xist and other loci is compatible with the hypothesis that “stacking” of imperfect
repressive tendencies may be an evolutionary strategy to ensure leakproof gene silencing.
The Xist gene plays a central role in X chromosome dosage
compensation in eutherian mammals (7, 45). The product of
the gene is a nontranslated RNA that localizes to the inactive
X chromosome from which it is transcribed (4, 5). Female
embryonic stem cells and cells of the inner cell mass express
the Xist gene from both parentally derived X chromosomes,
but later expression from one X chromosome is enhanced,
while expression from the other allele is extinguished (35, 41,
42). Elevated expression of Xist is the earliest known marker of
X inactivation and leads to formation of a compartment that
lacks transcription machinery (8) and a sequence of alterations
to chromatin and DNA that secure the inactive chromosomal
state.
This study concerns the active X chromosome, whose Xist
allele is silenced embryonically and remains inert for the du-
ration of that somatic lifetime. Stable Xist silencing on the
active X chromosome in females and on the solitary X chro-
mosome of males is presumably of paramount importance if
inactivation of all X chromosomes is to be avoided. Early
studies showed that the promoter of the silenced Xist gene is
heavily methylated at CpG sites, whereas the active Xist pro-
moter is methylation free (1), and this has been confirmed in
detail by bisulfite sequencing (31). The hypothesis that silenc-
ing is mediated by DNA methylation was verified experimen-
tally through studies of DNA methylation-deficient mice,
which showed demethylation of the Xist promoter and fre-
quent reactivation of the gene (1, 36). More recently, it has
been shown that de novo DNA methylation is not required for
the initial establishment of Xist silencing on the active X chro-
mosome but is essential for the stability of the silent state (40).
There is ample evidence that DNA methylation can main-
tain repression of local gene expression, but the mechanism of
silencing is less well characterized. In model systems, two kinds
of mechanisms are shown to be potentially involved: (i) direct
blocking of access by transcription factors to DNA due to the
presence of methyl-CpG within the factor binding site (44) and
(ii) attraction of proteins with an affinity for methyl-CpG that
recruit corepressors to effect transcriptional shutdown (2, 3).
Seven mammalian methylated DNA binding proteins (MBPs)
are transcriptional repressors with an affinity for methylated
DNA: four of these (MeCP2, MBD2, MBD1, and MBD4) are
members of the MBD family (18, 24, 27), and three are mem-
bers of the Kaiso family (13, 37). Several of these MBPs are
shown to associate with corepressor complexes that have the
potential to modify chromatin structure (12, 21, 32, 33, 46).
The biological importance of MBPs can be assessed using
mice that carry null mutations in the respective genes. In this
way, endogenous target genes that bind to a methyl-CpG bind-
ing protein (MBP) in vivo and are developmentally deregu-
lated in the absence of that protein have begun to emerge.
Ectopic expression of interleukin-4 (IL-4) and gamma inter-
feron (IFN-) in T helper cells of the immune system was
reported to occur in Mbd2/ mice (20), and increased basal
expression of the brain-derived neurotrophic factor gene was
observed in neurons of Mecp2-null mice (9, 29). In transformed
cell lines, cases of aberrant gene silencing by DNA methylation
have also been shown to involve Mbd2 (28) and Kaiso (46).
Here we have asked whether the DNA methylation-mediated
silencing of the Xist gene on the active X chromosome depends
upon methyl-CpG binding proteins. We find that Mbd2 is
involved but that the other tested MBPs are not implicated.
Mbd2 mediates robust histone deacetylation at the Xist chro-
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matin, and its activity depends on the “maintenance DNA
methyltransferase” Dnmt1.
MATERIALS AND METHODS
Western blotting. For Western blotting, proteins were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto a Protran
membrane (Schleicher & Schuell). Blots were blocked in 5% milk–Tris-buffered
saline, incubated with primary antibody (anti-Dnmt1 PATH52 [1:10,000; a gift
from Tim Bestor] or anti-glyceraldehyde-3-phosphate dehydrogenase [anti-
GAPDH; 1:5000; Abcam]) for 120 min. After being washed and incubated with
secondary antibody (horseradish peroxidase-conjugated anti-rabbit or anti-
mouse antibody; 1:10,000; Amersham), proteins were visualized using enhanced
chemiluminescence.
Retroviral infection. The Flag-tagged version of the mouse Mbd2 cDNA was
subcloned into the pBMN-ZIN retroviral vector, which permits expression of a
Flag-tagged protein of interest and of the neomycin resistance gene from a
bicistronic mRNA. Virus was produced in Phoenix cells after transfecting either
pBMN-ZIN Flag-Mbd2 or empty pBMN-ZIN (mock transfection), and then
mutant or wild-type (wt) mouse fibroblasts were infected with the virus according
to the Nolan Lab protocols (http://www.stanford.edu/group/nolan/protocols/pro
_helper_dep.html). Infected cell lines were maintained under G418 selection to
ensure expression in the vast majority of the cells. The efficiency of infection was
verified by indirect immunofluorescence using the anti-Flag M2 monoclonal
antibody (Sigma).
PCR. For reverse transcription, TRI reagent (Sigma) was used to purify total
RNA from male mouse tail fibroblasts. RNA (0.5 g) was DNase treated (RQ
DNase; Promega) and reverse transcribed in a 50-l reaction mixture containing
1 mM deoxynucleoside triphosphate mix, 5 M of random hexamer primers, 1 U
of RNasin (Promega), and 1 U of Moloney murine leukemia virus reverse
transcriptase (Promega). Control samples without the reverse transcriptase
served to check for contaminating DNA and were consistently negative. For
real-time (RT)-PCR, a mastermix of 1.2 l of cDNA sample was mixed with 10
l of iQ SYBR green supermix (Bio-Rad) and 7.2 l distilled water followed by
1.6 l of the appropriate primers (3.2 pmol/l). Reactions were performed in an
iCycler iQ multicolor RT-PCR detection system (Bio-Rad) using the following
steps: 95°C for 1 min 30 s for predenaturation, followed by 95°C for 30 s, 60°C for
30 s, and 72°C for 15 s, for a total of 45 cycles. Signals were normalized to the
GAPDH signal. Primers used for RT-PCR were Dnmt1-3F (AAGTGCCCCG
AGTGTG), Dnmt1-3R (AGGTGGAGTCGTAGATGG), Gapdh p3 (TACCC
CCAATGTGTCCGTCG), Gapdh p4 (CCTGCTTCACCACCTTCTTG), XIST-4R
(CACATTGCTTGATCACGCTG), XIST-10F (ACTGCTACCCTACTCATG
CC), XIST-7F (AGCAAGCCCACAATTCTGG), and XIST-11R (GGACTGC
CAGCAGCCTATAC).
For PCR genotyping of the different cell lines, 28 cycles were performed as
described above, followed by an additional extension step of 2 min at 72°C. The
primers were Kaiso-F (TCCTCTTGCAGAATACCGCACC), Kaiso-R (AGT
CCCCAGAAGGATCTTGAC), M2b-RT-F-3 (GATGAAGACATTAGGAAA
CAGG), M2b-RT-R-3 (GTCCATGTCAATGTCTACTTCC), MBD1_F (AGA
CGGCAGATGCTCCAGAGG), MBD1-Ex15-R (CCCAGGCTGAAAATCTC
CGTG), MeCP2-F (TCGCTCTGCTGGAAAGTATGATGTA), and MeCP2 (C
TCCCACCTTTTAAAATATGCAATCA).
Chromatin immunoprecipitation (ChIP). Cells were cross-linked for 10 min by
adding formaldehyde to the culture medium to a final concentration of 1%. Cells
were washed twice with ice-cold phosphate-buffered saline (supplemented with
0.5 mM phenylmethylsulfonyl fluoride), harvested, and resuspended in 100 l
ice-cold lysis buffer (1% sodium dodecyl sulfate, 10 mM EDTA, 50 mM Tris-HCl
[pH 8.1], 0.5 mM phenylmethylsulfonyl fluoride, and Complete protease inhib-
itor cocktail [Roche Diagnostics]). After incubation on ice for 10 min, 500 l of
the cell suspension was sonicated on ice for 3 min at a 30% duty cycle for 5-s
pulses with 10-s gaps (Branson 250 Sonifier). The cross-links were reversed by
adding 1.2 l 5 M NaCl per 20 l chromatin at 65°C for 4 to 5 h. Washed
Sepharose A (Amersham Biosciences) was used for rabbit and mouse antibodies
and Sepharose G for the sheep Mbd2 antibody. Prewashed beads were incubated
with 1 ml of chromatin sample for 2 h at 4°C and centrifuged at 1,000 rpm. The
antibodies (10 g control polyclonal or 5 l Mbd2 antiserum) were added to the
supernatant and rotated at 4°C overnight. S923 is an anti-Mbd2 antibody that was
raised in this laboratory (33), anti-acetylated H4 antibodies were from Upstate,
and the anti-Flag antibody was from Sigma. The irrelevant control antibody was
rabbit polyclonal anti-alpha amylase antibody (Sigma). DNA fragments were
amplified using primers XIST-7F and XIST-11R (see above) and the following
primers: F2 (GTGTCCAAGACGCGGAGATAC), R2 (CAAACATGGCTGG
AGCAAGCC), F3 (CGTGATACGGCTATTCTCGAG), and R3 (CCATTGC
TACACACCAGAACA). The sequences for primers XIST-7F/XIST-11R are
given above.
siRNA transfection. Short interfering RNA (siRNA) against Dnmt1 was de-
signed according to the siRNA user guide from the Tuschl laboratory, Rocke-
feller University. The siRNA D1-4 targeting sequence 5-AAGTCGGACAGT
GACACCCTT-3, siRNA D1-22 targeting sequence 5-AAGTGCAAGGCGT
GCAAAGAT-3, and siRNA D1-33 targeting sequence 5-AACTTCGTGTCC
TACAGACGC-3 were synthesized by QIAGEN custom siRNA service. Male
murine tail fibroblasts (wt and Mbd2 knockout) were seeded at 20% confluence
and grown for 16 to 24 h in Dulbecco modified Eagle’s medium (Cambrex)
supplemented with 4 mM L-glutamine (Cambrex), 10% donor bovine serum
(Gibco), and 10 units/ml penicillin-streptomycin solution (Cambrex). The next
day, 40 M siRNA was transfected into the cells using Oligofectamine reagent
(Invitrogen) by following the manufacturer’s instructions. Control cells were
treated with the same amount of scrambled negative-control siRNA (no. 1 from
Ambion). Cells were split 48 h later and transfected twice more before being
harvested for analysis.
Bisulfite sequencing. Bisulfite sequencing was conducted essentially as de-
scribed previously (34). DNA was purified using the PCR purification kit
(QIAGEN) and eluted in 30 l distilled water. The CpG-rich region of the Xist
promoter was amplified by two rounds of PCR amplification using nested prim-
ers. For the first round of amplification, primers BS3 (TAAAGGTTTAATAA
GATGTTAGAA) and BS4 (AAATAAATCCACCATACACA) were used for a
total of 45 cycles with an annealing temperature of 54°C; for the second round of
amplification, primers BS5 (TGTAATTTTTGTGGTTATTTTTTTT) and BS6
(ATATTCCCCCAAAACTCCTTAAATA) were used and annealed at 58°C for
a total of 35 cycles. Both PCR amplification reactions were carried out in a 50-l
reaction mixture containing 3.2 pmol of each primer, 1 mM dCTP and dGTP, 2
mM dATP and dTTP, 1.25 U of Taq DNA polymerase (Roche), and 1 reaction
buffer. PCR products were separated on a 2.5% agarose gel and purified using a
gel extraction kit (QIAGEN). PCR cycles were carried out as follows: 94°C for
45 s, 54°C or 58°C for 45 s, and 72°C for 45 s. Purified PCR products were cloned
using TOPO TA cloning kits (Invitrogen) before sequencing.
In situ hybridization. Mouse Xist RNA was detected by in situ hybridization
using probe GPT16, a 6-kb DNA probe spanning most of exon 1 which was a gift
from T. Nesterova. Hybridization was performed as described previously (11).
RNase treatment abolished the hybridization signal (data not shown). Between
500 and 3,000 nuclei of cells of each genotype/drug treatment were scored for
localized Xist expression. The aggregate number of Xist-positive nuclei was used
to derive an overall percentage. Cells were treated with 5-azacytidine for 5 days
and with trichostatin A (TSA) for 24 h. When both drugs were used together,
TSA was added at the end of the TSA treatment regime.
RESULTS
Xist silencing is compromised by the absence of Mbd2. We
chose to study Xist repression in male cells, since the analysis
is uncomplicated by the additional presence of an inactive X
chromosome. Simian virus 40-transformed fibroblast cell lines
were derived from the tails of mice that were either wt or
mutated in one or more of the methyl-CpG binding domain
protein genes, Mbd2, Mecp2, or Kaiso (19, 38). In addition,
male Mbd1-null mouse embryonic fibroblasts were examined
(48). Reverse transcriptase PCR of RNA from independent
tail fibroblast cell lines (Fig. 1A) and embryonic fibroblasts
(Fig. 1B) used in this study established that wt cells bear all of
these genes, whereas single, double, and triple mutant cells
lack only the appropriate mRNAs. Dnmt1 was expressed in
each cell line.
The Xist gene is highly repressed in wt male cells, but low-
level expression was detected by quantitative RT-PCR using
two primer pairs (XIST-4R/XIST-10F and XIST-7F/XIST-
11R) that amplified different regions of the Xist sequence and
are specific for the spliced RNA product (Fig. 1C). We asked
whether the absence of any of the MBPs caused increased
expression of the Xist gene. Comparison of mutants with mu-
tations in the Mbd2, Mbd1, Mecp2, and Kaiso genes with wt
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cells showed a consistent 3-fold increase in Xist expression in
Mbd2-deficient cells but no significant change in the other
single mutant cell lines (Fig. 1D). In particular, Mbd2/
Mecp2/Y double mutants and Mbd2/ Mecp2/Y Kaiso/Y
triple mutant cells showed levels of Xist induction that were
similar to those of Mbd2/ single mutant cells (Fig. 1D). The
slightly more elevated expression seen in Mecp2/y Mbd2/
double mutant than in Mbd2/ single mutant cells was con-
sistently seen in this pair of cell lines but not in independent
lines with the same genotypes (data not shown). We were
therefore unable to conclude that MeCP2 contributes to the
silencing of Xist. The experiments implicate Mbd2 in Xist re-
pression but argue against the involvement of Mbd1, MeCP2,
or Kaiso in this process. To test whether the absence of Mbd2
affected the degree of methylation in the Xist CpG island, we
carried out bisulfite sequencing of the region in Mbd2/ cells.
Complete methylation was observed at all tested CpGs (Fig.
1E), suggesting that the absence of the Mbd2 repressor, rather
than the alteration of Xist gene methylation in the mutant cells,
is responsible for the effect.
Mbd2 binds the Xist gene and restores defective silencing.
The Xist promoter is silenced, in part at least, by dense meth-
ylation of its CpG-rich promoter (36). As Mbd2 is a protein
that can recruit the NuRD corepressor to methylated DNA, we
considered the hypothesis that Mbd2 binds directly to the Xist
gene and contributes to the formation of transcriptionally inert
chromatin. To test this, we used ChIP to determine whether
Mbd2 protein is associated with the silent Xist allele. Precipi-
tated DNA was amplified by primer pairs corresponding to the
CpG island (F3/R3) and downstream regions of the transcrip-
FIG. 1. Expression of Xist in mouse fibroblasts lacking Mbd2. (A) Reverse transcriptase PCR analysis of expression of Mbd2, Kaiso, MeCP2,
Mbd1, and Dnmt1 in a selection of tail fibroblast cell lines that lack one or more of the corresponding genes due to targeted mutation. Genotypes
(shown above panel) match the expression of each gene. (B) Same as for panel A, but using Mbd1/ and control mouse embryonic fibroblasts.
(C) Diagram of the Xist gene showing exons (black bars) and the CpG island region (black lollipops) that becomes methylated on the active X
chromosome. PCR primers XIST-7F/XIST-11R and XIST-4R/XIST-10F distinguish the processed RNA from genomic DNA. Primers F2/R2 and
F3/R3 were used for analysis of immunoprecipitated chromatin. The gray box denotes the region tested by bisulfite sequencing. Chr X,
chromosome X; FR2, primer pair F2/R2; FR3, primer pair F3/R3; 7/11, primer pair XIST-7F/XIST-11R; 4/10, primer pairs XIST-4R/XIST-10F.
(D) RT-PCR analysis of Xist expression in cell lines lacking one or more MBPs as shown in panel A. The primers were XIST-7F/XIST-11R (darkly
shaded bars) and XIST-4R/XIST-10F (lightly shaded bars). Expression levels relative to Gapdh mRNA as an internal control were normalized by
setting the level in wt cells to 1. (E) Bisulfite analysis of the Xist gene promoter region (see panel B) confirms persistence of heavy methylation
in Mbd2/ fibroblasts.
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tion unit (XIST-7F/XIST-11R; Fig. 1B). The data showed that
both regions of Xist were precipitated with an Mbd2-specific
antibody (Fig. 2A). That this antibody was genuinely specific for
Mbd2 was demonstrated by parallel immunoprecipitation of
Mbd2-null cells, which reproducibly detected no Xist sequences
(Fig. 2A).
To be sure that Mbd2 was the key factor behind Xist reac-
tivation in Mbd2-null cells, we asked whether exogenous Mbd2
expressed from a retroviral vector (pBMN-ZIN Flag-Mbd2)
was able to reverse the derepression of Xist seen in Mbd2/
fibroblasts. Western blots confirmed that the retrovirus di-
rected the expression of Mbd2 protein (Fig. 2B). Quantitative
RT-PCR established that the full repression level characteris-
tic of wt cells was restored in Mbd2-deficient cells by the
expression of retrovirally encoded Mbd2 (Fig. 2C). These re-
sults establish that the absence of Mbd2 is responsible for the
increased Xist expression in these cells and effectively rule out
the possibility that secondary changes in the cell lines, unre-
lated to the absence of Mbd2, are responsible. To find out
whether the virus-expressed Mbd2 localized to the Xist gene,
we carried out ChIP with the anti-Mbd2 antibody. Cells trans-
fected with empty virus were negative for immunoprecipitated
Xist gene fragments, but cells expressing retrovirus-encoded
Mbd2 gave a positive signal when amplified with Xist gene
primers (Fig. 2D). The data show that endogenous Mbd2 is
normally bound to the methylated Xist gene and, when absent,
can be replaced by exogenous Mbd2, which both restores re-
pression and binds to the methylated Xist gene.
Mbd2 reinforces histone deacetylation at the Xist gene. As
Mbd2 can associate with a corepressor complex that contains
histone deacetylases (HDACs) (12, 33), we asked whether Xist
expression in the absence of Mbd2 was more sensitive to the
HDAC inhibitor TSA. Using a quantitative PCR assay (Fig.
3A), we observed that treatment of the wt cells with TSA
induced Xist expression approximately 2.5-fold. As shown
above, the absence of Mbd2 also induced Xist two- to three-
fold, but when these mutant cells were additionally treated
with TSA, a 17-fold induction of Xist was observed (see Fig.
3A). The result was verified using independently isolated tail
fibroblast lines from different mice with the same genotype
(data not shown). The synergy between the removal of Mbd2
and treatment with TSA indicates that Mbd2 deficiency ren-
ders Xist repression more sensitive to inhibition of HDACs.
In order to directly visualize Xist expression, we performed
fluorescence in situ hybridization using a probe against Xist
RNA. We observed a discrete focus of Xist accumulation in the
nuclei in about 1% of Mbd2/ cells (Fig. 3B), but no Xist foci
were seen in wt cells (not shown). TSA treatment caused 0.3
to 0.5% of wt cells to become Xist RNA positive, whereas
TSA-treated Mbd2-null cells gave 10 times more Xist RNA-
positive cells (3 to 5%) (Fig. 3A, lower panel). The close
similarity between the RNA measurements and the fraction of
Xist-positive nuclei (Fig. 3A, compare upper and lower panels)
indicates that both the absence of Mbd2 and the exposure to
TSA cause activation of Xist by increasing the probability that
a particular nucleus will activate Xist, leading to the coating of
the X chromosome with the RNA.
Is the deacetylated status of Xist gene chromatin on the
active X chromosome (23, 30) altered by the absence of Mbd2?
An antibody against the acetylated N-terminal tail of histone
H4, a marker of transcriptionally active chromatin, precipi-
tated equivalent low levels of the methylated Xist CpG island
from wt and Mbd2/ cells in a ChIP experiment (Fig. 3C). We
conclude that H4 deacetylation at Xist is maintained despite
the absence of Mbd2. Mbd2/ cells were, however, signifi-
cantly more sensitive to TSA treatment. H4 acetylation at the
Xist gene was 6-fold higher in wt but 80-fold higher in
Mbd2/ cells after exposure to TSA (Fig. 3C). The TSA
sensitivities of Xist chromatin acetylation and Xist gene expres-
sion therefore match, with Mbd2-null cells being approximately
1 order of magnitude more sensitive than wt cells.
The role of Dnmt1 in silencing of Xist. Previous work has
shown that depletion of the “maintenance” DNA methyltrans-
ferase Dnmt1 compromises Xist repression (17, 36). We veri-
fied this in our fibroblasts using siRNA directed against the
Dnmt1 transcript. When Dnmt1 expression was reduced in wt
cells by about 50% using siRNA, as measured by quantitative
RT-PCR and Western blotting (Fig. 4A and B), a 10- to 15-fold
increase in Xist expression was observed (average of four in-
dependent experiments). This level of Xist induction following
moderate depletion of Dnmt1 is greater than that caused by
the absence of Mbd2 (two- to fourfold), indicating that Dnmt1
causes transcriptional repression of Xist via pathways that do
not involve Mbd2. Depletion of Dnmt1 in Mbd2/ cells, how-
ever, consistently caused a synergistic induction of Xist expres-
sion 50 to 80 times that of the wt level (Fig. 4A). This synthetic
effect of double deficiency for Mbd2 and Dnmt1 points to
FIG. 2. Mbd2 associates with the Xist gene and restores Xist re-
pression in Mbd2-null cells. (A) Immunoprecipitation (IP) of cross-
linked chromatin with an anti-Mbd2 antibody reveals that endogenous
Mbd2 is associated with the CpG island (primers F3/R3) and down-
stream regions (primers XIST-7F/XIST-11R) of the methylated Xist
gene. in, input; -ve, negative. (B) Exogenous Mbd2 is expressed from
retroviral vector pBMN-ZIN Flag-Mbd2 (pBM) or empty vector
pBMN-ZIN (pB) in Mbd2-null cells as detected on a Western blot
using antibodies against Mbd2 or the Flag epitope tag. (C) Elevated
Xist expression in Mbd2-null cells is abolished by exogenous Mbd2
expression. Levels of Xist RNA were measured by quantitative PCR
analysis as described in the legend for Fig. 1B and C using primers
XIST-7F/XIST-11R and XIST-4R/XIST-10F. Rel., relative. (D) Exog-
enous Mbd2 associates with the Xist gene in Mbd2-null cells. ChIP of
cells transformed with the Mbd2-expressing vector (pBMN-ZIN Flag-
Mbd2) or empty vector (pB) was done as described for panel A.
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cooperation between these proteins in bringing about effective
Xist silencing.
We next asked whether Dnmt1 deficiency, as induced by the
drug 5-azacytidine, would have a synergistic effect on Xist gene
derepression when combined with TSA treatment (6). When
these treatments were combined using Mbd2-deficient cells,
Xist RNA was induced 800-fold (Fig. 4C). In contrast, wt
cells responded much more weakly to the double treatment
FIG. 3. Synergy between histone deacetylation and Mbd2 in silencing the Xist gene. (A) TSA collaborates with Mbd2 deficiency to cause
enhanced activation of Xist transcription as measured by both RT-PCR analysis of Xist RNA using primers XIST-7F/XIST-11R (upper panel) and
counting of Xist-positive (ve) cells in the microscope (lower panel). Xist RNA was visualized in treated and untreated cells by in situ hybridization
as described in Materials and Methods. (B) Xist-positive foci (red) within TSA-treated Mbd2-null cell nuclei stained with DAPI (4,6-diamidino-
2-phenylindole). (C) Enhanced histone acetylation in Mbd2-null cells treated with TSA as measured by ChIP with an antibody against pan-acetyl
H4 and quantitative RT-PCR of the Xist gene (primers XIST-7F/XIST-11R; see Fig. 1C). Values are expressed as the percentage of input
precipitated. As a control, samples were precipitated with an irrelevant antibody and processed the same way (right-hand bar in each pair).
FIG. 4. Xist expression is dependent on Mbd2 and Dnmt1. (A) Quantitative PCR analysis of the effects of siRNA against Dnmt1 (D1) on
transcription of Dnmt1 (upper panel) and Xist (lower panel) in wt (/) and Mbd2-null (/) cells. Scrambled siRNA (sc) was a negative control.
Rel., relative; expr., expression. (B) Depletion of Dnmt1 in wt and Mbd2/ cells as determined by Western blotting in comparison with GAPDH.
(C) Induction of Xist expression by treatment of wt and Mbd2-null cells with TSA (T), 5-azacytidine (A), or both drugs (TA). Xist expression
levels were normalized against the level of expression of Gapdh RNA.
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with TSA and 5-azacytidine, showing a 20-fold induction of
Xist. These results strongly reinforce the notion that Mbd2
shares a repressive pathway with both Dnmt1 and HDACs.
DISCUSSION
DNA methylation at the Xist locus is read by Mbd2. We
demonstrate that the methyl-CpG binding protein Mbd2 is
required for the leakproof silencing of the Xist gene in mouse
fibroblasts. In wt male fibroblasts, Xist-bearing cells are unde-
tectable, but about 1% of Mbd2-null cells exhibit a coating of
the X chromosome by Xist RNA. Thus, the absence of Mbd2
increases the probability that Xist gene reactivation will occur.
Previous studies reported that artificial demethylation reacti-
vated Xist in about 1% of hypomethylated human fibroblasts
(17), while in Dnmt1-deficient differentiated mouse embryonic
stem cells, about 15% of cells carried Xist (36). Therefore,
deficiency of either DNA methylation or Mbd2 increases the
probability of Xist reactivation but does not cause Xist reex-
pression in every cell. This weakening of Xist repression recalls
the effects of Mbd2 deficiency on T helper cells, where it was
found that only a proportion of Mbd2-null T helper cells re-
activate IL-4 and IFN- inappropriately (20). As in the case of
Xist, a lack of Mbd2 increased the probability of inappropriate
activation of IL-4 and IFN-.
Expression of Xist is synergistically increased when both
Mbd2 and Dnmt1 are deficient. The simplest interpretation of
the relationship between these two proteins is that Mbd2 reads
the DNA methylation signal that has been added to the locus
by Dnmt1. The data also make clear, however, that Mbd2 is
not the only mediator of silencing through Dnmt1, as the
induction of Xist expression by Dnmt1 deficiency is consistently
greater than that caused by the absence of Mbd2 (15-fold
versus 2.5-fold). The additional contribution of Dnmt1 could
be caused by direct interference of DNA methylation with
transcription factor access or by the involvement of MBP re-
pressors other than those tested here. An alternative possibility
is that Dnmt1 itself contributes to Xist repression through its
association with HDACs (14, 39). Under this scenario, Mbd2
may read the methylation signal while Dnmt1 directly partici-
pates in the repression process. The mechanism by which
Dnmt1 might target repression is unclear, as it is not known to
specifically complex with DNA except during catalysis follow-
ing DNA replication. A potential interaction between Dnmt1
and Mbd2 could in theory contribute to specificity (43).
Xist was induced 20-fold by TSA treatment of Mbd2-null
cells, whereas either Mbd2 deficiency or TSA treatment of wt
cells induced Xist only two- to threefold each. In agreement
with these results, TSA treatment resulted in 8-fold higher
Xist chromatin acetylation levels in Mbd2-null cells than in wt
cells. Biochemical data have consistently shown Mbd2 to be
associated with the NuRD corepressor complex, which in-
cludes HDAC1 and HDAC2 (12, 25, 26, 33, 47). Therefore,
Mbd2-null cells are likely to recruit less HDAC1 and HDAC2
to methylated sites at the Xist gene, and this may explain the
heightened sensitivity of the Xist gene to TSA treatment. An
alternative hypothesis is that there is increased turnover of
acetyl groups on histone H4 in Mbd2/ cells, with the steady-
state acetylation levels remaining much the same (see Fig. 3C).
Inhibition with TSA might then enhance H4 acetylation by
perturbing the steady-state level of HDAC activity, resulting in
Xist transcription. The mutual interdependence of Mbd2, his-
tone deacetylation, Dnmt1, and Xist gene expression is well
illustrated by the massive induction of Xist (2 to 3 orders of
magnitude above that of wt cells) when Mbd2-null cells are
simultaneously depleted in Dnmt1 and exposed to TSA. The
data are compatible with a scenario in which DNA methylation
recruits NuRD, which in turn causes local deacetylation of chro-
matin, leading to leakproof transcriptional silencing of Xist.
Do MBPs work solo or as a team? Our findings shed light on
the specificity of methyl-CpG binding proteins. Model experi-
ments have shown previously that Kaiso, Mbd1, Mbd2, and
MeCP2 can repress transcription, but do they compete to re-
press a particular methylated gene? Given their common DNA
binding sequence specificities, it might be expected that the
absence of one MBP would be compensated for by the con-
tinued presence of the others. An alternative scenario pro-
poses that a particular MBP is dedicated to a specific subset of
genes that is different from the subsets that are targeted by
other MBPs. Recent analysis of target sites for Mbd2 and
MeCP2 showed clearly that these proteins occupy distinct sites
in vivo, strongly favoring the second hypothesis (22). Our data
are also compatible with distinct, nonoverlapping functions for
MBPs, as Xist repression depends on Mbd2 but is unaffected by
the removal of Mbd1, MeCP2, or Kaiso. Even weak collabo-
rations between these proteins should have been detected by
combining the absence of Mbd2 with deficiencies of other Mbd
proteins. No such synthetic effects were seen, leading to the
conclusion that, in these cells at least, only Mbd2 participates
in Xist repression. The earlier observation that the neurologi-
cal phenotype seen in Mecp2-null mice is not enhanced in
Mecp2 Mbd2 double null mice (16) also fits with independent
MBP functioning.
Gene silencing by “stacking” repressive tendencies. Al-
though Mbd2 does not appear to collaborate with other MBPs
at the Xist locus, it does collaborate with other gene-silencing
mechanisms. Deacetylation of histone H4 was superficially
normal in the chromatin of both wt and Mbd2-null cells (see
Fig. 3C). It follows that HDACs are active at the Xist locus
even when Mbd2 is not present and must be recruited by other
components of the machinery that has evolved to repress Xist.
The Mbd2 pathway is evidently just one of several epigenetic
mechanisms that collaborate to efficiently silence Xist.
Why should repression mechanisms be redundant in this
way? One possibility is that each mechanism is moderately
efficient but not efficient enough to guarantee the continuous
silence of Xist in all cells. By enlisting several such mechanisms
at a single locus, the probability that all will fail simultaneously
is reduced. A paradigm for redundant, repressive mechanisms
working in tandem is X chromosome inactivation. Here, Xist
RNA, polycomb group proteins, histone deacetylation, histone
(H3K9) methylation, histone H2aX substitution, late replica-
tion, and DNA methylation are all involved in silencing. The
synergy of several of these mechanisms has been demonstrated
experimentally (10) and resembles the redundancy of Xist re-
pression mechanisms reported here. Conceivably, it is more
parsimonious from an evolutionary perspective to “stack” im-
perfect silencers in this way than to create a single “perfect”
silencing mechanism. A prerequisite of the “stacked tendency”
model is that each imperfect mechanism in the stack is inde-
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pendent of the others (i.e., does not share limiting compo-
nents). If so, their likelihoods of failure can be multiplied
together, resulting in efficient shutdown of the gene concerned.
For example, three independent, 90% efficient mechanisms
directed at the same target gene would combine to give 99.9%
efficient silencing. A prediction of this model is that the loss of
any one member of the stack (e.g., by mutation) would leave
repression largely intact but would be manifest as an increase
in transcriptional leakiness. This may help to explain the rel-
atively mild phenotype resulting from gene mutations of some
MBPs and of certain other proteins that target corepressors to
DNA, for example, Ikaros (15).
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